HARP insider transactions
Harpoon Therapeutics Inc. (HARP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for HARP
- New Leaf Biopharma Opportunities Ii, L.P. returned 1,859,169 shares to the company and returned 10,000 units of 8.000% Series A Redeemable Preferred Stock to the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Hunt Ronald was granted 424 shares, returned 1,872,393 shares to the company and returned 10,000 units of 8.000% Series A Redeemable Preferred Stock to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Silvernail Lauren P returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Walker Luke Nathaniel returned 135,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Myers Scott Dunseth returned 22,665 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Chin Mark returned 13,224 shares to the company and was granted 424 shares, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Drachman Jonathan G was granted 415 shares and returned 5,415 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Robbins Andrew R returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Lanza Frank J returned 18,734 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Eastland Julia Marie returned 269,381 shares to the company and was granted 31,250 shares, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Bailes Joseph S returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Bucher James B4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Merck & Co., Inc. bought $492,135,715 worth of shares (21,397,205 units at $23.00) (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- New insider Merck & Co., Inc. claimed no ownership of stock in the company (SEC Form 3)3 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Eastland Julia Marie was granted 178,500 shares, increasing direct ownership by 334% to 232,003 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Lanza Frank J was granted 15,000 shares, increasing direct ownership by 446% to 18,362 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Walker Luke Nathaniel was granted 115,000 shares, increasing direct ownership by 575% to 135,000 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Myers Scott Dunseth was granted 2,048 shares, increasing direct ownership by 10% to 22,666 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Chin Mark was granted 1,072 shares, increasing direct ownership by 9% to 12,801 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Hunt Ronald was granted 1,072 shares, increasing direct ownership by 9% to 12,801 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Bucher James B4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 3 filed by new insider Bucher James B3 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Walker Luke Nathaniel was granted 20,000 shares (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Lanza Frank J was granted 2,000 shares, increasing direct ownership by 147% to 3,362 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Eastland Julia Marie was granted 50,000 shares, increasing direct ownership by 1,427% to 53,503 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Silvernail Lauren P was granted 5,000 shares (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Robbins Andrew R was granted 5,000 shares (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Myers Scott Dunseth was granted 5,000 shares, increasing direct ownership by 32% to 20,618 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Hunt Ronald was granted 5,000 shares, increasing direct ownership by 74% to 11,729 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Drachman Jonathan G was granted 5,000 shares (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Chin Mark was granted 5,000 shares, increasing direct ownership by 74% to 11,729 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Bailes Joseph S was granted 5,000 shares (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Myers Scott Dunseth was granted 5,797 shares, increasing direct ownership by 59% to 15,618 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Hunt Ronald was granted 3,035 shares, increasing direct ownership by 82% to 6,729 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- Chin Mark was granted 3,035 shares, increasing direct ownership by 82% to 6,729 units (SEC Form 4)4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Chin Mark4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Myers Scott Dunseth4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Silvernail Lauren P4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Robbins Andrew R4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Myers Scott Dunseth4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Drachman Jonathan G4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Chin Mark4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Bailes Joseph S4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Viney Joanne L.4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Myers Scott Dunseth4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Colowick Alan4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Chin Mark4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 3: New insider New Leaf Biopharma Opportunities Ii, L.P. claimed ownership of 3,156,699 shares and claimed ownership of 10,000 units of 8.000% Series A Redeemable Preferred Stock3 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Lanza Frank J4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Walker Luke Nathaniel4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Eastland Julia Marie4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Lanza Frank J4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Walker Luke Nathaniel4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 3: New insider Walker Luke Nathaniel claimed no ownership of stock in the company3 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 3: New insider Lanza Frank J claimed ownership of 6,540 shares3 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)
- SEC Form 4 filed by Silvernail Lauren P4 - Harpoon Therapeutics, Inc. (0001708493) (Issuer)